Coiled-coil scaffolds for Targeted Protein Degradation
Korona, B.; Mylemans, B.; Acevedo-Jake, A.; Huang, D. T.; Edwards, T. A.; Wilson, A. J.; Woolfson, D.; Itzhaki, L. S.
Show abstract
In targeted protein degradation (TPD) the cells quality control machinery is co-opted to degrade proteins of interest. Currently TPD is limited by the availability of small-molecule binders for targets and the many potential human E3 ubiquitin ligases. Consequently, other approaches are needed to tackle new targets and to exploit degradation pathways fully. The natural binding epitopes for E3s and other degradation machineries are often short linear peptide motifs, which offer routes to new biologics-based degraders. Here, targeting the anti-apoptotic BCL-xL and initiation of apoptosis, we show that several protein-degradation pathways--ubiquitination, direct proteasome, autophagy-lysosome recruitment--can be leveraged by integrating target-binding and degradation motifs into single-polypeptide constructs. This exploits versatile and varied de novo coiled-coil scaffolds as adaptable molecular glues by presenting motifs multivalently and in diverse arrangements. The constructs are small ({approx}80 residues) and provide a plug-and-play platform to map and optimise target-degradation space using rational design. We call this Coiled Coils for induced Proximity (CoCoProx) and propose its use for targeted degradation and other induced-proximity reactions.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation 96%
- A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader 95%
- Peptide-mediated inhibition of the transcriptional regulator Elongin BC induces apoptosis in cancer cells 95%
Similar papers in this journal
- Structure-guided bifunctional molecules hit a DEUBAD-lacking hRpn13 species upregulated in multiple myeloma 96%
- Protein mimetic amyloid inhibitor potently abrogates cancer-associated mutant p53 aggregation and restores tumor suppressor function 95%
- Development of a First-in-Class RIPK1 Degrader to Enhance Antitumor Immunity 95%
Similar papers in this journal
Similar papers in this journal
- Degron-based bioPROTACs for controlling signaling in CAR T cells 96%
- Engineering single pan-specific ubiquibodies for targeted degradation of all forms of endogenous ERK protein kinase 95%
- Natural and designed proteins inspired by extremotolerant organisms can form condensates and attenuate apoptosis in human cells 95%
Similar papers in this journal
- Designer small molecule control system based on Minocycline induced disruption of protein-protein interaction. 95%
- Development of a new DHFR-based destabilizing domain with enhanced basal turnover and applicability in mammalian systems 94%
- Confounding factors in targeted degradation of short-lived proteins 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.